ENGR. H. B. NO. 3041 Page 1 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
SENATE FLOOR VERSION
March 28, 2024
ENGROSSED HOUSE
BILL NO. 3041 By: Stinson of the House
and
Stanley of the Senate
An Act relating to stem cell research; amending 63
O.S. 2021, Section 1 -270.2, which relates to
permissible stem cell resear ch and reports to the
Governor and Legislature; adding an exception to the
filing requirement; and providing an effective date .
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. AMENDATORY 63 O.S. 2021, Section 1 -270.2, is
amended to read as follows:
Section 1-270.2 A. For the purposes of the Advancement in Stem
Cell Cures and Therapies Act, "human embryo" means a living organism
of the species Homo sapiens at the earliest stage of development,
including the single-cell stage, that is not located in the body of
a woman.
B. Research on human tissue regeneration and human diseases
using adult stem cells and stem cells obtained from umbilical cord
ENGR. H. B. NO. 3041 Page 2 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
blood and amniotic fluid may be conducted in this state, provided
that the research is performed:
1. Safely and ethically;
2. Only on embryonic stem cell lines created prior to August 1,
2001, and in accordance with federal law as it existed on November
1, 2007; and
3. Without the use of a human embryo, including a huma n embryo
produced using cloning technology.
C. When research is performed in accordance with the
Advancement in Stem Cell Cure s and Therapies Act, a person or
governmental body shall not:
1. Restrict public funds designated for the stem cell research;
or
2. Obstruct or provide disincentives for the stem cell
research.
D. The State Department of Health shall establish a reporting
system that collects information regarding all activities carried
out in accordance with this section.
E. The Department shal l submit a report with all information
collected pursuant to subsection D of this section to the Governor,
the Speaker of the O klahoma House of Representatives, and the
President Pro Tempore of the Oklahoma State Senate no later than
December 31 of each ye ar.
ENGR. H. B. NO. 3041 Page 3 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
F. Provided that there is no stem cell research to report that
year, the Department does not need to file a report.
SECTION 2. This act shall become effective November 1, 2024.
COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVIC ES
March 28, 2024 - DO PASS